ASK THE EXPERT SESSION Understanding The Key Criteria Investors Use When Selecting Biotech to Fund

Identifying how clinical strategy and data quality impact investment decisions
Translating investor expectations into practical changes in trial design and execution
Applying these insights to improve funding strategy in a tougher market